Dynamic pdf

This site is intended for U.S. healthcare professionals.

Visit Pfizer Medical

Log Out

Therapy Areas

Products

Order Vaccines

Order Samples

Order

Materials

Request Samples

Hospital Products

Vaccines

Patient Assistance

Pfizer Oncology Together

Pfizer RxPathways

Pfizer Dermatology Patient Access

Explore Content

Contact

About PAXLOVID

About
PAXLOVID

Example of description text sitting alongside header

High-Risk Factors & When to Treat

Dosing

Mechanism of Action

Efficacy

Example of description text sitting alongside header

Trial Design

Results

Real-World Evidence

Drug Interactions

Safety

Access & Resources

Example of description text sitting alongside header

Access

Download Co-Pay Card

Resources for Healthcare Providers

Frequently Asked Questions

Request a Visit From a Representative

To report an adverse event, please call 1-800-438-1985

Pfizer for Professionals 1-800-505-4426

This site is intended only for U.S. healthcare professionals. The products discussed in this site may have different product labeling in different countries. The information provided is for educational purposes only.

© 2025 Pfizer Inc. All rights reserved.

PP-C1D-USA-1773

INDICATION

PAXLOVID is indicated for the treatment of mild-to-moderate coronavirus disease 2019 (COVID-19) in adults who are at high risk for progression to severe COVID-19, including hospitalization or death.

Limitations of Use

PAXLOVID is not approved for use as pre-exposure or post-exposure prophylaxis for prevention of COVID-19.

Please see Full Prescribing Information, including BOXED WARNING and Patient Information